MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 6 filers reported holding MANNKIND CORP in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | 0.0% | 7,750 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | -44.4% | 7,750 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | -25.0% | 7,750 | 0.0% | 0.00% | – |
| Q1 2016 | $12,000 | +9.1% | 7,750 | 0.0% | 0.00% | – |
| Q4 2015 | $11,000 | +22.2% | 7,750 | +163.1% | 0.00% | – |
| Q3 2015 | $9,000 | +12.5% | 2,946 | +100.3% | 0.00% | – |
| Q2 2015 | $8,000 | 0.0% | 1,471 | 0.0% | 0.00% | – |
| Q1 2015 | $8,000 | -99.0% | 1,471 | -97.9% | 0.00% | -100.0% |
| Q2 2014 | $769,000 | -17.9% | 70,000 | -70.0% | 0.02% | -20.7% |
| Q1 2014 | $937,000 | -10.1% | 233,000 | +16.5% | 0.03% | -14.7% |
| Q4 2013 | $1,042,000 | +82.8% | 200,000 | +100.0% | 0.03% | +70.0% |
| Q3 2013 | $570,000 | +75.4% | 100,000 | +100.0% | 0.02% | +81.8% |
| Q2 2013 | $325,000 | +91.2% | 50,000 | 0.0% | 0.01% | +83.3% |
| Q1 2013 | $170,000 | -26.4% | 50,000 | -50.0% | 0.01% | -33.3% |
| Q4 2012 | $231,000 | -19.8% | 100,000 | 0.0% | 0.01% | -25.0% |
| Q3 2012 | $288,000 | +25.8% | 100,000 | 0.0% | 0.01% | +20.0% |
| Q2 2012 | $229,000 | -7.3% | 100,000 | 0.0% | 0.01% | -9.1% |
| Q1 2012 | $247,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
| Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
| AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
| B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
| ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
| Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
| Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
| Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
| Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |